Following the first approvals in the U.K., Canada, Australia and Switzerland, the EMA’s Committee for Medicinal Products for ...

Medtronic plc received U.S. FDA approval for Altaviva, a minimally invasive implantable tibial neuromodulation device ...

At the ongoing European Association for the Study of Diabetes annual meeting in Vienna, Hanmi Holdings Co. Ltd. presented preclinical efficacy data on HM-15275, a long-acting GLP-1/GIP/glucagon ...

Two back-to-back papers published in Nature on Sept. 10, 2025, shed new light on the unexpected role of neurons in shaping the evolution of small-cell lung cancer (SCLC). It’s already known that, in ...

Osteosarcoma, the most common bone cancer in children and young adults, has poor outcomes after relapse with only ~18% 5-year survival, underscoring the urgent need for new therapies. Researchers from ...

A committee of the House of Representatives advanced a bill that if passed will give eligible breakthrough medical devices ...

The U.S. FDA cleared 18 drugs in August, comparable to July’s 17 but down from June’s 23 approvals. That brings the 2025 U.S.

Beijing QL Biopharmaceutical Co. Ltd.’s once-monthly GLP-1 receptor agonist, zovaglutide (ZT-002), met its primary and ...

Inc. debuted on the Hong Kong Stock Exchange on its second attempt at an IPO, raising HK$1.819 billion (US$234 million).

A novel mRNA drug, 3’UTRMYC1-18 (UTRxM1-18), has demonstrated notable efficacy in preclinical models of aggressive pancreatic ...

Biopharma happenings, including deals and partnerships, and other news in brief: Arvinas, Alcyone, Austrianova, Avant, Biocardia, Biogen, Bluebird, Genetix, Klothonova, Infinimmune, Immunome, Novo ...

Organox Ltd.’s normothermic machine perfusion device, Metra, has been cleared by the U.S. FDA for use during air transport. The greenlight from the regulatory body paves the way for the broader use of ...